Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice

Open access

Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice

The present experiment was aimed at assessing the application of neostigmine, an acetylcholinesterase (AChE) pseudo-irreversible inhibitor with poor penetration through the hematoencephalitic barrier, and the neurotransmitter acetylcholine (ACh). The experiment was done to evaluate their ability to modulate an infectious disease: tularemia. Mice infected with Franciselle tularensis and exposed to either ACh or neostigmine had a higher mortality and spleen bacterial burden when compared to infected mice exposed to saline solution only. The activated cholinergic anti-inflammatory pathway suppressed pathways necessary for tularemia resolution. Administration of AChE inhibitors to the individuals suffering from tularemia is contra-indicatory. Drugs based on AChE inhibition should be restricted when tularemia or disease with a similar pathogenesis is suspected.

Anthony LSD, Burke RD and Nano FE. (1991). Growth of Francisella spp. in rodent macrophages. Infect Immun 59: 3291-3296.

Bandouchova H, Sedlackova J, Pohanka M, Novotny L, Hubalek M, Treml F, Vitula F and Pikula J. (2009a). Tularemia induces different biochemical responses in BALB/c mice and common voles. BMC Infect Dis 9: 101.

Bandouchova H, Sedlackova J, Hubalek M, Pohanka M, Peckova L, Treml F, Vitula F and Pikula J. (2009b). Susceptibility of selected murine and microtine species to infection by a wild strain of Francisella tularensis subsp. holarctica. Vet Med (Czech) 54: 64-74.

Bell BL, Mohapatra NP and Gunn JS. (2010). Regulation of virulence gene transcripts by the Francisella novicida orphan response regulator PmrA: role of phosphorylation and evidence of MGlA/SspA interaction. Infect Immun 78: 2189-2198.

Bergsbaken T and Cookson BT. (2009). Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation. J Leukoc Biol 86: 1153-1158.

Bosio CM. (2011). The subversion of the immune system by Francisella tularensis. Frontiers in Microbiology, www.frontiersin.org, volume 2, article 9, doi: 10.3389/frmicb.2011.00009 www.frontiersin.org

Elkins KL, Colombini SM, Krieg AM and De Pascalis R. (2009). NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS. Microbes Infect 11: 49-56.

Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott E, Eisenlohr L, Landel CP and Alnemri ES. (2010). The AIM2 inflammmasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11: 385-393.

Fortier AH, Green SJ, Polsinelli T, Jones TR, Crawford RM, Leiby DA, Elkins KL, Meltzer MS and Nacy CA. (1994). Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser 60: 349-361.

Fujii T, Mori Y, Tominaka T, Hayasaka I and Kawashima K. (1997). Maintenance of constant blood acetylcholine content bofore and after feeding in young chimpanzees. Neurosci Lett 227: 21-24.

Fulop M, Mastoeni P, Green M and Titball RW. (2001). Role of antibody to lipopolysacharide in protection against low - and high - virulence strains of F. tularensis. Vaccine 19: 4465-4472.

Jae SY, Heffernan KS, Yoon ES, Lee MK, Fernhall B and Park WH. (2009). The inverse assoctiation between cardiorespiratory fitness and C-reative protein is mediated by autonomic function: a possible role of the cholinergic anti-inflammatory pathway. Mol Med 15: 291-296.

Kaufer D, Friedman A, Seldman S and Soreq H. (2003). Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393: 373-377.

Kepp O, Galluzzi L, Zitvogel L and Kroemer G. (2010). Pyroptosis - a cell death modality of its kind. Eur J Immunol 40: 627-630.

Kopman AF and Eikermann M. (2009). Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia 64: 22-30.

Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, Guglani L, Alcorn JF, Strawbridge H, Park SM, Onishi R, Nyugen N, Walter MJ, Pociask D, Randall TD, Gaffen SL, Iwakura Y, Kolls JK and Khader SA. (2009). Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799-810.

Lykkesfeldt J. (2007). Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380: 50-58.

Pohanka M, Pavlis O and Skladal P. (2007). Diagnosis of tularemia using piezoelectric biosensor technology. Talanta 71: 981-985.

Pohanka M, Bandouchova H, Novotny L, Pavlis O, Treml F, Sedlackova J and Pikula J. (2009). Assessment of low-molecular-weight antioxidants in Francisella tularenis infected hosts: comparison of two rodents with different susceptibility to tularemia. Neuro Endocrinol Lett 30 (suppl. 1): 186-191.

Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M, Yang L, Valdes-Ferrer SI, Patel NB, Chavan S, Al-Abed Y, Yang H and Tracey KJ. (2009). The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med 15: 195-202.

Sotnikova R, Ponist S, Navarova J, Mihalova D, Tomekova V, Strosova M and Bauerova K. (2009). Effects of sesame oil in the model of adjuvant arthritis. Neuro Endocrinol Lett 30 (suppl 1): 22-24.

Tracey KJ. (2002). The inflammatory reflex. Nature 420: 853-859.

Tracey KJ. (2009). Reflex control of immunity. Natur Rev Immunol 9: 418-428.

Tyagi E, Agrawal R, Nath C and Shukla R. (2010). Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation. Neurochem Int 56: 135-142.

Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susaria S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ and Tracey KJ. (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388.

Yamamoto K, Sawada Y and Iga T. (1995). Comparative pharmacokinetics of four cholinesterase inhibitors in rats. Biol Pharm Bull 18: 1292-1295.

Yee D, Rhinebbart-Jones TR and Elkins L. (1996). Loss of either CD4+ or DC8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen Francisella tularensis strain LVS. J Immunol 157: 5042-5048.

Interdisciplinary Toxicology

The Journal of Institute of Experimental Pharmacology of Slovak Academy of Sciences

Journal Information


CiteScore 2018: 1.78

SCImago Journal Rank (SJR) 2018: 0.274
Source Normalized Impact per Paper (SNIP) 2018: 0.671

Cited By

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 191 120 5
PDF Downloads 85 59 6